News
Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback